Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Grows By 50.0%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,400 shares, a growth of 50.0% from the August 31st total of 1,600 shares. Based on an average daily volume of 62,800 shares, the days-to-cover ratio is currently 0.0 days.

Enzon Pharmaceuticals Stock Down 0.8 %

Shares of ENZN traded down $0.00 during mid-day trading on Friday, hitting $0.12. 32,100 shares of the company’s stock were exchanged, compared to its average volume of 25,530. Enzon Pharmaceuticals has a 52 week low of $0.06 and a 52 week high of $0.24. The stock’s 50-day simple moving average is $0.15 and its 200-day simple moving average is $0.13.

Enzon Pharmaceuticals Company Profile

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.